Table 1 KEGG pathway enrichment analysis of differential expression proteins
From: ITRAQ-based quantitative proteomic analysis of Cynops orientalis limb regeneration
Kegg pathway | Numbers of proteins | p-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
3 dpa | 7 dpa | 14 dpa | 30 dpa | 42 dpa | 3 dpa | 7 dpa | 14 dpa | 30dpa | 42dpa | |
ko04512 ECM-receptor interaction | 7 | / | 6 | 6 | / | 0.000188 | / | 0.016531 | 0.032279 | / |
ko04974 Protein digestion and absorption | 5 | 6 | 6 | 6 | / | 0.000825 | 0.001014 | 0.000898 | 0.001982 | / |
ko05150 Staphylococcus aureus infection | 6 | 13 | 7 | / | / | 0.005453 | 0.001032 | 0.014634 | / | / |
ko05414 Dilated cardiomyopathy | 8 | 13 | 13 | 14 | 15 | 0.011778 | 0.001032 | 0.00083 | 0.001001 | 0.000197 |
ko04145 Phagosome | 8 | 12 | 16 | 14 | 12 | 0.016209 | 0.005786 | 2.12E-05 | 0.001828 | 0.01271 |
ko05410 Hypertrophic cardiomyopathy (HCM) | 7 | 13 | 12 | 14 | 14 | 0.023807 | 0.000398 | 0.001273 | 0.000359 | 0.000269 |
ko05152 Tuberculosis | 6 | 8 | 10 | 9 | / | 0.025194 | 0.029589 | 0.002179 | 0.020763 | Â |
ko04610 Complement and coagulation cascades | 4 | 6 | / | / | / | 0.035686 | 0.012969 | / | / | / |
ko05310 Asthma | 2 | / | / | / | / | 0.04069 | / | / | / | / |
ko04260 Cardiac muscle contraction | / | 9 | 10 | 8 | 8 | / | 0.001908 | 0.000315 | 0.016778 | 0.014398 |
ko00020 Citrate cycle (TCA cycle) | / | 4 | / | 4 | / | / | 0.017886 | / | 0.027372 | / |
ko00280 Valine, leucine and isoleucine biosynthesis | / | 2 | / | 2 | / | / | 0.020492 | / | 0.026165 | / |
ko03010 Ribosome | / | 7 | / | 8 | 8 | / | 0.028186 | / | 0.016778 | 0.014398 |
ko00620 Pyruvate metabolism | / | 4 | / | / | / | / | 0.028656 | / | / | / |
ko04612 Antigen processing and presentation | / | / | 6 | 6 | 7 | / | / | 0.001748 | 0.00378 | 0.000409 |
ko04670 Leukocyte transendothelial migration | / | / | 9 | / | / | / | / | 0.006172 | / | / |
ko03050 Proteasome | / | / | 4 | / | / | / | / | 0.009282 | / | / |
ko04510 Focal adhesion | / | / | 13 | / | / | / | / | 0.01106 | / | / |
ko05133 Pertussis | / | / | 5 | / | / | / | / | 0.017658 | / | / |
ko00860 Porphyrin and chlorophyll metabolism | / | / | 3 | / | / | / | / | 0.021891 | / | / |
ko05110 Vibrio cholerae infection | / | / | 5 | / | / | / | / | 0.025512 | / | / |
ko05110 Pathogenic Escherichia coli infection | / | / | 8 | / | / | / | / | 0.032446 | / | / |
ko05140 Leishmaniasis | / | / | 5 | / | / | / | / | 0.0353 | / | / |
ko05322 Systemic lupus erythematosus | / | / | 5 | / | / | / | / | 0.047123 | / | / |
ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) | / | / | 6 | / | / | / | / | 0.049575 | / | / |
ko05134 Legionellosis | / | / | / | 5 | / | / | / | / | 0.031754 | / |
ko00040 Pentose and glucuronateinterconversions | / | / | / | / | 3 | / | / | / | / | 0.030341 |
ko00860 Porphyrin and chlorophyll metabolism | / | / | / | / | 3 | / | / | / | / | 0.030341 |
ko00053 Ascorbate and aldarate metabolism | / | / | / | / | 3 | / | / | Â | / | 0.003884 |